Organogenesis (ORGO +3.9%) announces it has withdrawn the previously announced revenue guidance for FY20, due to the impact of COVID-19.
Company reported preliminary 1Q20 results, expects
Net revenue between $61M and $61.6M, up 7% to 8% from last year, vs.
consensus of $60.64M; and net revenue from PuraPly products between
$32.1M and $32.5M, up by 26% to28% from last year.
Company to report 1Q20 financial results after the market closes on May 11, 2020.
https://seekingalpha.com/news/3559494-organogenesis-reports-preliminary-1q20-revenue-and-withdraws-fy20-revenue-guidance
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.